About SEEK LABS, INC
Seek Labs is a molecular medicine company focused on developing programmable CRISPR therapeutics and point-of-care diagnostics using AI-driven genomic intelligence. The company aims to address emerging diseases by rapidly translating sequence data into targeted interventions.
Development of programmable CRISPR therapeutics (Sequence Ablation Therapeutics)Creation of point-of-care molecular diagnostics (SeekIt Diagnostics)AI-powered genomic intelligence engine (BioSeeker) for identifying disease targetsRapid response to emerging pathogens through pre-mapped disease targetsDeployment of molecular testing without lab infrastructure or electricity
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SEEK LABS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.